Amira S. Gouda

A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling

Hoda M. Marzouk, Mamdouh R. Rezk, Amira S. Gouda et al. · Microchemical Journal · 2021 · 99 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +9

A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers

Mosaad I. Morsy, Eman G. Nouman, Youmna M. Abdallah et al. · Journal of Pharmaceutical and Biomedical Analysis · 2021 · 75 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

A validated LC-MS/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian volunteers

Amira S. Gouda, Hoda M. Marzouk, Mamdouh R. Rezk et al. · Journal of Chromatography B · 2022 · 56 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +6

Development a validated highly sensitive LC–MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma: Application to a human pharmacokinetic study

Ola M. Abdallah, Ahmed M. Abdel‐Megied, Amira S. Gouda · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Development and validation of LC‐MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study

Ola M. Abdallah, Ahmed M. Abdel‐Megied, Amira S. Gouda · Biomedical Chromatography · 2018 · 45 citations

Pharmacy, Pharmacokinetics, Pharmacology +17